アステラス製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2024/01/24 | 1,711.5 | 1,718 | 1,702 | 1,703 | -21.5 | -1.2% | 7,092,700 |
2024/01/23 | 1,715 | 1,734 | 1,714 | 1,724.5 | +14.5 | +0.8% | 6,749,400 |
2024/01/22 | 1,705 | 1,716.5 | 1,698 | 1,710 | ±0 | ±0% | 7,908,000 |
2024/01/19 | 1,710.5 | 1,733 | 1,707.5 | 1,710 | -6.5 | -0.4% | 7,385,400 |
2024/01/18 | 1,744 | 1,758 | 1,715.5 | 1,716.5 | -25 | -1.4% | 9,201,600 |
2024/01/17 | 1,790 | 1,801.5 | 1,741.5 | 1,741.5 | -42 | -2.4% | 10,787,100 |
2024/01/16 | 1,760.5 | 1,786.5 | 1,757.5 | 1,783.5 | +26 | +1.5% | 6,392,700 |
2024/01/15 | 1,755.5 | 1,763 | 1,749 | 1,757.5 | +3.5 | +0.2% | 4,896,900 |
2024/01/12 | 1,800 | 1,800 | 1,747.5 | 1,754 | -10 | -0.6% | 9,901,600 |
2024/01/11 | 1,782 | 1,785 | 1,756 | 1,764 | +1 | +0.1% | 9,077,200 |
2024/01/10 | 1,744 | 1,770.5 | 1,743 | 1,763 | +24.5 | +1.4% | 8,374,600 |
2024/01/09 | 1,726 | 1,756 | 1,721.5 | 1,738.5 | -27.5 | -1.6% | 8,674,400 |
2024/01/05 | 1,762.5 | 1,784.5 | 1,757.5 | 1,766 | +17 | +1% | 8,687,700 |
2024/01/04 | 1,716.5 | 1,749 | 1,701.5 | 1,749 | +63 | +3.7% | 8,582,600 |
2023/12/29 | 1,681.5 | 1,690 | 1,675.5 | 1,686 | +1.5 | +0.1% | 5,307,500 |
2023/12/28 | 1,679 | 1,689.5 | 1,670.5 | 1,684.5 | +7 | +0.4% | 4,803,700 |
2023/12/27 | 1,660 | 1,682 | 1,658 | 1,677.5 | +10 | +0.6% | 6,046,300 |
2023/12/26 | 1,674.5 | 1,679 | 1,659.5 | 1,667.5 | -4 | -0.2% | 3,990,600 |
2023/12/25 | 1,682 | 1,684 | 1,671 | 1,671.5 | +1.5 | +0.1% | 2,450,600 |
2023/12/22 | 1,666 | 1,677.5 | 1,663.5 | 1,670 | +16.5 | +1% | 5,015,000 |
2023/12/21 | 1,662.5 | 1,669.5 | 1,651 | 1,653.5 | -18.5 | -1.1% | 4,806,900 |
2023/12/20 | 1,684 | 1,695.5 | 1,672 | 1,672 | +2.5 | +0.1% | 6,669,500 |
2023/12/19 | 1,640 | 1,671 | 1,635 | 1,669.5 | +37 | +2.3% | 8,025,700 |
2023/12/18 | 1,610 | 1,641 | 1,600.5 | 1,632.5 | +18.5 | +1.1% | 8,116,100 |
2023/12/15 | 1,638.5 | 1,653.5 | 1,608 | 1,614 | -45.5 | -2.7% | 13,883,300 |
2023/12/14 | 1,675 | 1,685 | 1,640.5 | 1,659.5 | -28.5 | -1.7% | 11,143,100 |
2023/12/13 | 1,700.5 | 1,707 | 1,682 | 1,688 | -13.5 | -0.8% | 8,906,000 |
2023/12/12 | 1,740 | 1,749 | 1,701 | 1,701.5 | -28 | -1.6% | 8,542,100 |
2023/12/11 | 1,722.5 | 1,742 | 1,721.5 | 1,729.5 | -15.5 | -0.9% | 7,292,200 |
2023/12/08 | 1,776.5 | 1,778 | 1,745 | 1,745 | -42 | -2.4% | 10,899,300 |
2023/12/07 | 1,805 | 1,806 | 1,782.5 | 1,787 | -22.5 | -1.2% | 6,486,200 |
2023/12/06 | 1,792.5 | 1,813.5 | 1,790 | 1,809.5 | +19 | +1.1% | 5,238,500 |
2023/12/05 | 1,797.5 | 1,797.5 | 1,780.5 | 1,790.5 | -3 | -0.2% | 5,357,400 |
2023/12/04 | 1,800 | 1,801 | 1,777 | 1,793.5 | -13 | -0.7% | 5,674,500 |
2023/12/01 | 1,810 | 1,814 | 1,795.5 | 1,806.5 | +9 | +0.5% | 4,955,600 |
2023/11/30 | 1,787.5 | 1,802 | 1,778 | 1,797.5 | +9.5 | +0.5% | 15,673,200 |
2023/11/29 | 1,782 | 1,800 | 1,772.5 | 1,788 | -14.5 | -0.8% | 6,367,400 |
2023/11/28 | 1,823.5 | 1,826.5 | 1,797 | 1,802.5 | -22 | -1.2% | 7,634,200 |
2023/11/27 | 1,830 | 1,839.5 | 1,824.5 | 1,824.5 | +7.5 | +0.4% | 6,319,300 |
2023/11/24 | 1,830 | 1,832.5 | 1,816.5 | 1,817 | +8.5 | +0.5% | 5,596,200 |
2023/11/22 | 1,803.5 | 1,825 | 1,800.5 | 1,808.5 | +1 | +0.1% | 4,873,500 |
2023/11/21 | 1,827 | 1,827.5 | 1,802 | 1,807.5 | -1 | -0.1% | 7,131,900 |
2023/11/20 | 1,786 | 1,818.5 | 1,782 | 1,808.5 | +28 | +1.6% | 9,123,200 |
2023/11/17 | 1,760.5 | 1,781 | 1,757 | 1,780.5 | +29 | +1.7% | 7,125,600 |
2023/11/16 | 1,774 | 1,781.5 | 1,751.5 | 1,751.5 | -19.5 | -1.1% | 8,328,000 |
2023/11/15 | 1,756 | 1,775 | 1,748 | 1,771 | +15.5 | +0.9% | 9,769,400 |
2023/11/14 | 1,769 | 1,772 | 1,752 | 1,755.5 | -5 | -0.3% | 6,830,000 |
2023/11/13 | 1,788 | 1,790 | 1,753 | 1,760.5 | -29.5 | -1.6% | 10,510,100 |
2023/11/10 | 1,778 | 1,795 | 1,772 | 1,790 | -17.5 | -1% | 9,036,800 |
2023/11/09 | 1,801 | 1,817 | 1,783.5 | 1,807.5 | +16.5 | +0.9% | 8,461,200 |
251~
300
件表示中 / 3631件
類似銘柄と比較する
現在ご覧いただいている「アステラス薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
アステラス薬 | 151,400円 | +18.5% | -96.0% | 4.89% | 193.61倍 | 1.77倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
武 田 | 420,900円 | +7.7% | +206.9% | 4.66% | 56.54倍 | 0.96倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
大塚HD | 813,600円 | +14.4% | +120.8% | 1.47% | 18.21倍 | 1.67倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
塩野義 | 229,000円 | +5.7% | +3.9% | 2.50% | 11.39倍 | 1.51倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
エーザイ | 462,100円 | +1.7% | -2.9% | 3.46% | 30.32倍 | 1.59倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
市場注目の銘柄
チャート関連のコラム